Shanghai No1 Pharmacy Co Ltd Strategic Asset Allocation Index
Shanghai No1 Pharmacy Co Ltd strategic asset allocation index. Shanghai No1 Pharmacy Co Ltd (600833) has a Strategic Asset Allocation Index of 17.3% as of June 2023. Strategic assets (PP&E of CN¥174.63 Million plus long-term investments of CN¥-) total CN¥174.63 Million, measured against net assets of CN¥1.01 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Shanghai No1 Pharmacy Co Ltd (600833) balance sheet quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Shanghai No1 Pharmacy Co Ltd (2001–2021)
Strategic asset allocation index of Shanghai No1 Pharmacy Co Ltd from 2001 to 2021. This chart shows how Shanghai No1 Pharmacy Co Ltd's Strategic Asset Allocation Index has evolved across 21 annual periods from 2001 to 2021. As of June 2023, the index stands at 17.3%, representing strategic assets of CN¥174.63 Million against net assets of CN¥1.01 Billion CNY. Check 600833 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Shanghai No1 Pharmacy Co Ltd Strategic Asset Allocation Index by Year (2001–2021)
Shanghai No1 Pharmacy Co Ltd strategic asset allocation index by year from 2001 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Shanghai No1 Pharmacy Co Ltd from 2001 to 2021, covering 21 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 600833 company net worth.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 21.6% | CN¥167.98 Million | CN¥167.98 Million | CN¥- | CN¥777.92 Million | ▲ +11.9 pp |
| 2020 | 9.7% | CN¥72.47 Million | CN¥72.47 Million | CN¥- | CN¥749.32 Million | ▼ -0.6 pp |
| 2019 | 10.3% | CN¥75.41 Million | CN¥75.41 Million | CN¥- | CN¥732.34 Million | ▼ -30.6 pp |
| 2018 | 40.9% | CN¥273.83 Million | CN¥79.78 Million | CN¥194.05 Million | CN¥669.57 Million | ▼ -13.0 pp |
| 2017 | 53.9% | CN¥384.66 Million | CN¥86.20 Million | CN¥298.46 Million | CN¥714.07 Million | ▼ -7.1 pp |
| 2016 | 61.0% | CN¥448.61 Million | CN¥83.77 Million | CN¥364.84 Million | CN¥736.00 Million | ▼ -10.5 pp |
| 2015 | 71.4% | CN¥559.41 Million | CN¥88.24 Million | CN¥471.16 Million | CN¥783.09 Million | ▲ +57.5 pp |
| 2014 | 13.9% | CN¥90.47 Million | CN¥90.47 Million | CN¥- | CN¥650.97 Million | ▼ -16.0 pp |
| 2013 | 29.9% | CN¥160.40 Million | CN¥160.40 Million | CN¥- | CN¥536.14 Million | ▼ -3.2 pp |
| 2012 | 33.1% | CN¥165.29 Million | CN¥165.29 Million | CN¥- | CN¥499.84 Million | ▲ +4.3 pp |
| 2011 | 28.8% | CN¥123.67 Million | CN¥123.67 Million | CN¥- | CN¥429.41 Million | ▼ -1.4 pp |
| 2010 | 30.2% | CN¥131.64 Million | CN¥131.64 Million | CN¥- | CN¥435.88 Million | ▼ -1.7 pp |
| 2009 | 31.9% | CN¥128.44 Million | CN¥128.44 Million | CN¥- | CN¥402.25 Million | ▼ -11.3 pp |
| 2008 | 43.2% | CN¥135.80 Million | CN¥135.80 Million | CN¥- | CN¥314.16 Million | ▲ +5.1 pp |
| 2007 | 38.2% | CN¥150.17 Million | CN¥150.17 Million | CN¥- | CN¥393.54 Million | ▼ -25.4 pp |
| 2006 | 63.5% | CN¥156.14 Million | CN¥156.14 Million | CN¥- | CN¥245.77 Million | ▼ -1.6 pp |
| 2005 | 65.1% | CN¥151.59 Million | CN¥151.59 Million | CN¥- | CN¥232.68 Million | ▼ -27.9 pp |
| 2004 | 93.0% | CN¥188.48 Million | CN¥188.48 Million | CN¥- | CN¥202.62 Million | ▼ -14.0 pp |
| 2003 | 107.0% | CN¥202.71 Million | CN¥202.71 Million | CN¥- | CN¥189.49 Million | ▲ +2.1 pp |
| 2002 | 104.9% | CN¥184.99 Million | CN¥184.99 Million | CN¥- | CN¥176.31 Million | ▼ -3.8 pp |
| 2001 | 108.7% | CN¥179.96 Million | CN¥179.96 Million | CN¥- | CN¥165.52 Million | — |